impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Letters to the Editor

 

The active immunological profile in patients with primary Sjögren's syndrome is restricted to typically encountered autoantibodies

1, 2, 3, 4, 5, 6

 

  1. Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France.
  2. Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest; and Unit of Rheumatology, CHRU Cavale Blanche, Brest, France.
  3. Unit of Rheumatology, CHRU Cavale Blanche, Brest; and INSERM ESPRI, ERI29/EA2216, Innovative Medicines Initiative PRECISESADS, European University of Brittany, Brest, France.
  4. Unit of Rheumatology, CHRU Cavale Blanche, Brest; and INSERM ESPRI, ERI29/EA2216, Innovative Medicines Initiative PRECISESADS, European University of Brittany, Brest, France.
  5. Unit of Rheumatology, CHRU Cavale Blanche, Brest; and INSERM ESPRI, ERI29/EA2216, Innovative Medicines Initiative PRECISESADS, European University of Brittany, Brest, France.
  6. Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest; and INSERM ESPRI, ERI29/EA2216, Innovative Medicines Initiative PRECISESADS, European University of Brittany, Brest, France. yves.renaudineau@univ-brest.fr

CER9167
2016 Vol.34, N°4
PI 0722
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 27191916 [PubMed]

Received: 04/12/2015
Accepted : 01/02/2016
In Press: 09/05/2016
Published: 14/07/2016

Rheumatology Article